Modern skin treatments are designed to improve overall skin health while addressing concerns like tanning, pigmentation, uneven complexion, and dullness
Although manufacturers may be aware of some of these risks, some risks may have been under-reported or explained in order to keep profits up despite the harm they cause to people
View in: Pubmed Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Alongside that the pharma industry keeps working on newer obesity drug candidates, with a new oral GLP-1 from Eli Lilly and Company posting strong Phase III data
Even if the solution appears clear, bacterial contamination that is invisible to the eye can develop after 28 days
Introducing the concept of a hunger/fullness scale can support mindful eating and help patients better recognize satiety cues